4.7 Review

Optogenetics: What it has uncovered in potential pathways of depression

Journal

PHARMACOLOGICAL RESEARCH
Volume 152, Issue -, Pages -

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2019.104596

Keywords

Depression; Optogenetics; Neural circuits; Animal model; Translational circuit therapies

Funding

  1. NSFC (Natural Science Foundation of China) [31571126, 81871070, 31971078]
  2. Jilin Science and Technology Agency [20180519003JH, 20190701078GH, 20180414050GH]
  3. Jilin Province medical and health talents [2019SCZT007]

Ask authors/readers for more resources

Optogenetics is a biological technique, which involves controlling the biological functions of target cells using light. In recent years, optogenetics has become one of the most advanced experimental techniques in neuroscience. It provides precise control on target cells in addition to rapidly and specifically altering the neuronal activity both in vivo and ex vivo. The emergence of optogenetic technology enabled researchers to study the pathogenesis of diseases at the level of neurons and explore new ideas for the treatment of brain diseases. Depression is a highly prevalent and disabling mental disorder, which seriously impacts peoples work and life. Currently, our understanding of the occurrence, development, and treatment of depression has made great progress, but the exact pathogenesis of depression is still unclear. In this article, we summarize the applications of optogenetics in improving our understanding of depression and provide new insight for uncovering the potential pathways of depression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available